Mårten Fernö
71 – 80 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Abstract P2-10-28: The Prognostic Index, KiGE, Combining Proliferation, Histological Grade and Estrogen Receptor Status Challenges Gene Profiling – A Study in 1,854 Chemo-Naïve Women with N0/N1 Primary Breast Cancer.
Strand, C ; Bak, M ; Borgquist, S LU ; Chebil, G ; Falck, A-K ; Fjällskog, M-l ; Grabau, D LU ; Hedenfalk, I LU
; Jirström, K
LU
and Klintman, M
LU
, et al.
(2014)
In Cancer Research
72(24 Supplement).
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-10-19: Are the mitotic factors Mitotic Activity Index (MAI) and Phosphohistone 3 (PPH3) stronger prognostic proliferation factors than Ki67 in node-negative breast cancer?
- Contribution to journal › Published meeting abstract
-
Mark
A Prognostic Index Composed of Progesterone Receptor Status, Tumour Size and S-phase Fraction, Predicts Survival in Node-Negative Breast Cancer Patients in a Large Multicentre Prospective Cohort Study.
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Toward a Molecular Pathologic Classification of Urothelial Carcinoma.
- Contribution to journal › Article
-
Mark
The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer.
Klintman, Marie LU ; Forsare, Carina LU
; Ahlin, Cecilia
; Beglerbegovic, Sanda
; Fjällskog, Marie-Louise
; Grabau, Dorthe
LU
; Gudlaugsson, Einar
; Janssen, Emiel A M
; Lövgren, Kristina
LU
and Skaland, Ivar
, et al.
(2013)
In PLoS ONE
8(12).
- Contribution to journal › Article
-
Mark
Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial
- Contribution to journal › Article
-
Mark
G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
Broselid, Stefan LU ; Cheng, Benxu ; Sjöström, Martin LU ; Lövgren, Kristina LU ; Klug-De Santiago, Heather L P ; Belting, Mattias LU ; Jirström, Karin LU
; Malmström, Per
LU
; Olde, Björn
LU
and Bendahl, Pär-Ola
LU
, et al.
(2013)
In Clinical Cancer Research
19(7).
p.1681-1692
- Contribution to journal › Article
-
Mark
The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval - prognostic implications?
Grabau, Dorthe Aamand ; Bendahl, Pär-Ola LU ; Rydén, Lisa LU
; Stål, Olle
and Fernö, Mårten
LU
(2013)
In Acta Oncologica
52(8).
p.1657-1666
- Contribution to journal › Article
-
Mark
Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution.
Grabau, Dorthe LU ; Dihge, Looket LU ; Fernö, Mårten LU ; Ingvar, Christian LU and Rydén, Lisa LU
(2013)
In European Journal of Surgical Oncology
39(6).
p.601-607
- Contribution to journal › Article
-
Mark
A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial.
- Contribution to journal › Article